Somatic gene therapy for cardiovascular disease: Recent advances
- 30 April 1994
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 4 (2) , 57-63
- https://doi.org/10.1016/1050-1738(94)90010-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Neointima formation after vascular injury is angiotensin II mediatedBiochemical and Biophysical Research Communications, 1992
- Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries.Journal of Clinical Investigation, 1992
- Direct gene transfer into cardiac myocytes in vivoMethods, 1992
- Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.Circulation, 1992
- Behavior of genes directly injected into the rat heart in vivo.Circulation Research, 1992
- Gene transfer into cardiac myocytes in vivoTrends in Cardiovascular Medicine, 1991
- Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.Circulation Research, 1991
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977
- Transformation of rat cells by DNA of human adenovirus 5Virology, 1973
- Immunization by Selective Infection With Type 4 Adenovirus Grown in Human Diploid Tissue CultureJAMA, 1966